A Phase I trial of protracted oral fixed-dose temozolomide.

Jones, S.F., Greco, F.A., Gian, V.G., Miranda, F.T., Raefsky, E.L., Hainsworth, J.D., Willcutt, N.T., Beschorner, A.F., Kennerly, G., Burris, H.A.; Cancer. 2005 Nov 1.

Phase I. Trial of irinotecan plus carboplatin in two dose schedules.

Jones, S.F., Burris, H.A., Hainsworth, J.D., Yardley, D.A., Raefsky, E.A., Miranda, F.T., Kuzur, M.E., Willcutt, N.T., White, M.B., Greco, F.A.; Oncology (Williston Park). 2003 May.

Phase I. Trial of irinotecan and temozolomide in patients with solid tumors.

Jones, S.F., Gian, V.G., Greco, F.A., Miranda, F.T., Shipley, D.L., Thompson, D.S., Hainsworth, J.D., Toomey, M.A., Willcutt, N.T., Burris, H.A.; Oncology (Williston Park). 2003 May.